Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abeona Therapeutics (NQ: ABEO )

2.120 USD +0.140 (+7.07%)
Official Closing Price Updated: 7:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abeona Therapeutics

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
ABEO UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Abeona Therapeutics Inc. and a Lead Plaintiff Deadline of February 14, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased PlasmaTech... 
From PR Newswire
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ:ABEO) and... 
From GlobeNewswire News Releases
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Abeona Therapeutics Inc. - ABEO
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of: (1) PlasmaTech Biopharmaceuticals, Inc. securities from March 31, 2015... 
From PR Newswire
Abeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium™ 2017
Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, today announced that data on gene... 
From GlobeNewswire News Releases
EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Abeona Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017
Levi & Korsinsky reminds shareholders of Abeona Therapeutics of commencement of a class action lawsuit. 
From Business Wire News Releases
February 14th Deadline in Lawsuit for Investors in Abeona Therapeutics Inc (NASDAQ:ABEO) shares announced by Shareholders Foundation
From ACCESSWIRE
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017
From ACCESSWIRE
Deadline Upcoming in Lawsuit for Investors in Abeona Therapeutics Inc (NASDAQ:ABEO)
San Diego, CA -- (SBWIRE) -- 02/01/2017 -- A deadline is coming up on February 14, 2017 in the lawsuit filed for investors of Abeona Therapeutics Inc (NASDAQ:ABEO) over alleged securities laws... 
From SBWire - Latest Press Releases
Abeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type A
Abeona Therapeutics Inc. (Nasdaq:ABEO), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, announced today that the first high-dose... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
ABEO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Abeona Therapeutics Inc. and a Lead Plaintiff Deadline of February 14, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased PlasmaTech... 
From GlobeNewswire News Releases
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017
From ACCESSWIRE
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
Lundin Law PC, a shareholder rights firm announces a class action lawsuit against Abeona Therapeutics Inc., (“Abeona” or the “Company”) (Nasdaq: ABEO) concerning possible violations of federal... 
From Business Wire News Releases
ABEO INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Abeona Therapeutics Inc. and a Lead Plaintiff Deadline of February 14, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced on behalf of investors who purchased or Abeona Therapeutics Inc. securities. 
From Business Wire News Releases
IMPORTANT ABEO INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017
From ACCESSWIRE
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm
Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO). Investors who purchased or otherwise acquired... 
From Business Wire News Releases
ABEO LOSS NOTICE: Rosen Law Firm Reminds Abeona Therapeutics Inc. Investors of Important Feb. 14 Deadline in Class Action - ABEO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of: (1) PlasmaTech Biopharmaceuticals, Inc. securities from March 31, 2015 through June 19, 2015, both dates inclusive (the... 
From GlobeNewswire News Releases
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO). Investors who... 
From Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Abeona Therapeutics Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 – ABEO
The following statement is being issued by Levi & Korsinsky, LLP: 
From GlobeNewswire News Releases
Research Reports Initiation on Biotech Stocks -- Regulus Therapeutics, Abeona Therapeutics, Theravance Biopharma, and Sage Therapeutics
From PR Newswire
EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Abeona Therapeutics Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 - ABEO
From ACCESSWIRE
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-101 Gene Therapy in Sanfilippo Syndrome Type B
From GlobeNewswire News Releases
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.